Q BioMed Inc. Share Price Other OTC
Equities
QBIO
US74736N1054
Biotechnology & Medical Research
Sales 2021 | 0.2 16.24 | Sales 2022 | 0.28 23.61 | Capitalization | 13.49L 11Cr |
---|---|---|---|---|---|
Net income 2021 | -80L -66Cr | Net income 2022 | -20L -17Cr | EV / Sales 2021 | 7,99,67,019 x |
Net Debt 2021 | 27.09L 22Cr | Net Debt 2022 | 40.6L 34Cr | EV / Sales 2022 | 1,90,23,098 x |
P/E ratio 2021 |
-1.39
x | P/E ratio 2022 |
-0.2
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.01% |
Managers | Title | Age | Since |
---|---|---|---|
Denis Corin
CEO | Chief Executive Officer | 51 | 21/15/21 |
Ari Jatwes
DFI | Director of Finance/CFO | - | - |
Director/Board Member | 55 | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 55 | 01/15/01 | |
Denis Corin
CEO | Chief Executive Officer | 51 | 21/15/21 |
Rick Panicucci
BRD | Director/Board Member | 63 | 13/18/13 |
1st Jan change | Capi. | |
---|---|---|
+12.30% | 12TCr | |
+12.15% | 11TCr | |
-8.14% | 2.34TCr | |
-1.69% | 2.18TCr | |
-10.60% | 1.81TCr | |
-41.25% | 1.67TCr | |
-15.33% | 1.6TCr | |
+5.80% | 1.4TCr | |
+28.03% | 1.17TCr |